Trial intelligence / Profile preview

Flurbiprofen hydrogel medicated plaster for acute soft-tissue injury pain

2020-005217-41Phase 3Completed

Sponsor
Lead Chemical
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in soft tissue injury, sprain, muscle strain and 1 more comparing Flurbiprofen medicated plaster, Placebo plaster and Active comparator diclofenac plaster (3 arms). Primary endpoint: Primary efficacy endpoint. Started May 2021; status: completed.

02

Drugs

flurbiprofendiclofenac
03

Conditions

soft tissue injurysprainmuscle strainbruise

Beyond the preview

Go deeper on 2020-005217-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-005217-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call